Unitary Patent Court in the European Union (UPC) In a ruling by the Munich District Court, 10x GenomicsThe company was successfully obtained against Nasri Technologies (NanoString Technologies) Preliminary injunction. The verdict came in a trial1. 5Just days after the hearing (Less than2Time of week) made.

Nasri Technologies and10x GenomicsThe lawsuit involves a lawsuit concerning NoEP4108782A preliminary injunction on a European patent. 10x GenomicsFor Nasri TechnologiesCosMxSpace molecular imager (SMI) And used forRNAdetectingCosMxReagent inUPCA request for a preliminary injunction was filed in the jurisdiction.

Nasri Technologies, the defendant, announced in a press release, It will appeal against the ruling. At the same time, plaintiff10x GenomicsAlso thereUPCFiled a lawsuit against Nasri Technologies.

10x GenomicsBring a claim of infringement

American company10x GenomicsPoint out, Nasri Technologies forRNAdetectingCosMxThe use and sale of the product violates its serial numberEP4108782B1andEP2794928B1European patent. The two patents could be used to protect a spatial profiling technique. EP4108782B1Patent No. 1 is a unified patent, whileEP2794928B1Patent number is one "No opt-out" European patent. EP2794928B1Patent No. 1 is in Germany, The Netherlands and France are valid, whileEP4108782B1Is in allUPCValid in all member states.

towardsEP4108782B1Patent No, The judges held that the patent was valid, And was violated. therefore, They granted the patent owner's request for a preliminary injunction, Above ban at all17aUPCValid in all member States.

The ruling does not require a security deposit, So that means10x GenomicsThe judgment may be enforced immediately. This isUPCThe first preliminary injunction issued in his proceedings. merely, The European Patent Office concerning the patents in question (EPO) The opposition procedure is also pending.

Except forEP4108782B1No. Patent out of judgment, The court also heard10x GenomicsAim atEP2794928B1Another request for a preliminary injunction filed in Patent No. The relevant judgment will be in10month10diurnal. merely, Nasri Technologies is also offeringUPCAn action was filed to revoke the patent.

Nasri Technologies has suffered setbacks in Germany

In a lawsuit in Germany, Nasri Technologies has suffered a setback. The Munich District court banned the US manufacturer from selling two products in Germany. In addition, Against Nasri Technologies in the United States, A request to prevent the announcement and enforcement of the judgment of the German court, The district court also issued an injunction against counterclaims (AASI) .

The Munich District Court is this year5The month sent unilaterallyAASI. therewith, Nasri Technologies has withdrawn its counterclaim injunction in the United States (ASI) Apply for, And to the aboveAASIRaised an objection.

In opposition proceedings, The court heard at length the statements made by the two companies, But we still came to the same conclusion, Merge with7month20The objection was rejected by Nasri Technologies.

10x GenomicsMove on

At the same time, in10X GenomicsAfter the company has paid the corresponding deposit, Issued by the Munich District Court2A preliminary injunction was swiftly enforced. therewith, Nasri Technologies has filed an appeal with Munich's Higher Regional Court.

In addition to the above disputes, 10x GenomicsThe company is still hereUPCA separate lawsuit was filed in the Hamburg District Court, allegeVizgencorporateMerscopeSeries products violate itEP4108782B1Patent No. According to media reports, 10x GenomicsThe company is already in the United StatesVizgenThe company sued. (Be compiled fromwww. juve-patent. com)

TRANSLATORS: Liu Peng　proofread: Wang Dan



　　disclaimer: This network reprint or compile the original articles are from the network, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact us, This website will be corrected in due course, delete, thank you.